4.7 Article

Long-term association between seizure outcome and depression after resective epilepsy surgery

期刊

NEUROLOGY
卷 77, 期 22, 页码 1972-1976

出版社

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31823a0c90

关键词

-

资金

  1. NIH/NINDS [R01-NS32375]
  2. Epilepsy Foundation
  3. National EpiFellows Foundation
  4. NIH/NINDS
  5. Eisai Inc.
  6. British Pediatric Neurological Association
  7. Epilepsy Research Center (Melbourne)
  8. UCB
  9. American Epilepsy Society
  10. International League Against Epilepsy
  11. French National Foundation on Alzheimer's Disease and Related Disorders
  12. NIH
  13. Genentech, Inc.
  14. NIH (NIA, NINDS)
  15. US Veterans Administration Health Services Research and Development Service
  16. California Office of Statewide Health Planning and Development
  17. California Department of Public Health
  18. State of California Department of Health Services
  19. University of Pennsylvania Udall Center
  20. American Heart Association
  21. National Multiple Sclerosis Society
  22. SCAN Foundation
  23. Marinus Pharmaceuticals, Inc.
  24. Sunovion Pharmaceuticals Inc.
  25. Novartis
  26. Lundbeck Inc.
  27. Vertex Pharmaceuticals
  28. NeuroPace, Inc.
  29. Medtronics, Inc.
  30. Sepracor Inc.
  31. Finding a Cure for Epilepsy and Seizures (FACES)
  32. Pfizer Inc.

向作者/读者索取更多资源

Objective: This study explored the association between long-term epilepsy surgery outcome and changes in depressive symptoms. Methods: Adults were enrolled between 1996 and 2001 in a multicenter prospective study to evaluate outcomes of resective epilepsy surgery. The extent of depressive symptoms and depression case status (none, mild, or moderate/severe) were assessed using the Beck Depression Inventory (BDI) preoperatively and 3, 12, 24, 48, and 60 months postoperatively. A mixed-model repeated-measures analysis was performed, adjusting for covariates of seizure location, gender, age, race, education, and seizure control. Results: Of the total 373 subjects, 256 were evaluated at baseline and 5 years after surgery. At baseline, 164 (64.1%) were not depressed, 34 (13.3%) were mildly depressed, and 58 (22.7%) had moderate to severe depression. After 5 years, 198 (77.3%) were not depressed, 20 (7.8%) were mildly depressed, and 38 (14.8%) were moderately to severely depressed. Five years after surgery, the reduction in mean change from baseline in BDI score was greater in subjects with excellent seizure control than in the fair and poor seizure control groups (p = 0.0006 and p = 0.02 respectively). Those with good seizure control had a greater reduction in BDI score than the poor seizure control group (p = 0.02) and borderline significant reduction compared with the fair seizure control group (p = 0.055). Conclusion: Although study participants had initial improvement in depressive symptoms, on average, after resective surgery, only patients with good or excellent seizure control had sustained long-term improvement in mood. Neurology (R) 2011;77:1.972-1976

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据